After hours: January 8 at 6:02:41 PM EST Loading Chart for DGX ...

Quest Diagnostics Inc.’s DGX continued momentum in the base business is poised to help it grow in the upcoming quarters. The ongoing adoption of the highly specialized Advanced Diagnostics services is ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

BofA raised the firm’s price target on Quest Diagnostics (DGX) to $182 from $179 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Several research analysts recently issued reports on the stock. Barclays upped their price target on shares of Quest Diagnostics from $154.00 to $168.00 and gave the stock an “equal weight ...

Mizuho analyst Ann Hynes raised the firm’s price target on Quest Diagnostics (DGX) to $177 from $174 and keeps an Outperform rating on the shares in conjunction with publishing the firm’s 2025 ...

DGX has been the subject of several other research reports. Citigroup raised their target price on shares of Quest Diagnostics from $165.00 to $185.00 and gave the stock a “buy” rating in a ...